BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
Latest, Q2 2026
-49.4
Period ended Jun 30, 2026
Change on a year earlier
-25.8%
-66.6 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
42
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Investing cash flow ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | -49.4 | -25.8% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | -45.5 | -62.7% | Form 10-Q (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | -38.3 | -59.1% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | -49.3 | -63.2% | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | -66.6 | -40.0% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | -122 | -41.9% | Form 10-Q (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | -93.6 | +49.5% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2024 | Sep 30, 2024 | -134 | -28.1% | Form 10-Q (filed 2024-11-12) ↗ |
| Q2 2024 | Jun 30, 2024 | -111 | -263.7% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | -210 | -187.0% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | -62.6 | -262.6% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | -186 | -209.9% | Form 10-Q (filed 2023-11-09) ↗ |
| Q2 2023 | Jun 30, 2023 | 67.8 | -89.7% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 241 | +14.6% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 38.5 | -64.7% | Form 10-K (filed 2023-02-27) ↗ |
| Q3 2022 | Sep 30, 2022 | 170 | -1,512.5% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jun 30, 2022 | 659 | +161.8% | Form 10-Q (filed 2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 210 | -27.9% | Form 10-Q (filed 2022-05-09) ↗ |
| Q4 2021 | Dec 31, 2021 | 109 | -225.5% | Form 10-K (filed 2022-02-28) ↗ |
| Q3 2021 | Sep 30, 2021 | -12 | -99.2% | Form 10-Q (filed 2021-11-04) ↗ |
| Q2 2021 | Jun 30, 2021 | 252 | -158.5% | Form 10-Q (filed 2021-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 292 | -126.2% | Form 10-Q (filed 2021-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | -86.9 | +263.6% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | -1,537 | -819.4% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | -430 | -323.9% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 31, 2020 | -1,115 | -746.8% | Form 10-Q (filed 2020-05-11) ↗ |
| Q4 2019 | Dec 31, 2019 | -23.9 | -111.2% | Form 10-K (filed 2020-03-02) ↗ |
| Q3 2019 | Sep 30, 2019 | 214 | -143.5% | Form 10-Q (filed 2019-11-12) ↗ |
| Q2 2019 | Jun 30, 2019 | 192 | +463.0% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 172 | -143.7% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 213 | -412.6% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2018 | Sep 30, 2018 | -491 | +22.3% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jun 30, 2018 | 34.1 | -51.1% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | -394 | -1,006.7% | Form 10-Q (filed 2018-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | -68.2 | -60.0% | Form 10-K (filed 2018-02-28) ↗ |
| Q3 2017 | Sep 30, 2017 | -401 | -1,010.0% | Form 10-Q (filed 2017-11-13) ↗ |
| Q2 2017 | Jun 30, 2017 | 69.7 | -151.4% | Form 10-Q (filed 2017-08-09) ↗ |
| Q1 2017 | Mar 31, 2017 | 43.5 | +7.9% | Form 10-Q (filed 2017-05-10) ↗ |
| Q4 2016 | Dec 31, 2016 | -171 | -2,438.4% | Form 10-K (filed 2017-03-22) ↗ |
| Q3 2016 | Sep 30, 2016 | 44.1 | +600.0% | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2016 | Jun 30, 2016 | -136 | +79.0% | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2016 | Mar 31, 2016 | 40.3 | +1,159.4% | Form 10-Q (filed 2016-05-12) ↗ |
| Q4 2015 | Dec 31, 2015 | 7.30 | – | Form 10-K (filed 2017-03-22) ↗ |
| Q3 2015 | Sep 30, 2015 | 6.30 | – | Form 10-Q (filed 2016-11-10) ↗ |
| Q2 2015 | Jun 30, 2015 | -75.7 | – | Form 10-Q (filed 2016-08-10) ↗ |
| Q1 2015 | Mar 31, 2015 | 3.20 | – | Form 10-Q (filed 2016-05-12) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Investing cash flow ($M) ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_icf
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.